Radboud University Medical Centre:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Radboud University Medical Centre - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9382
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Radboud University Medical Centre (Radboud UMC), a subsidiary of Radboud University, is a university medical center that offers patient care, education, research, and scientific training services. The centre’s patient care services include basic care, tertiary care, top referral care, and transmural care. It offers university courses in the field of medicine sciences, dentistry, biomedical sciences, molecular life, and nursing courses. Radboud carries out research in the areas of oncology, cancer development, infectious diseases, inflammation and immunity, genetic and metabolic disease, neuroscience, molecular life sciences and evidence based medicine. The centre has operations in Nijmegen, Eindhoven and Oss. Radboud UMC is headquartered in Nijmegen, the Netherlands.

Radboud University Medical Centre – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Radboud University Medical Centre, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Radboud University Medical Centre, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Radboud University Medical Centre, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Radboud University Medical Centre, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Radboud University Medical Centre, Medical Devices Deals, 2012 to YTD 2018 9
Radboud University Medical Centre, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Radboud University Medical Centre, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Khondrion Enters into Collaboration Agreement with Nijmegen Center for Mitochondrial Disorders 11
Okklo Life Sciences Enters Into Agreement with Radboud University Nijmegen 12
Licensing Agreements 13
ProQR Therapeutics Enters into Licensing Agreement with Radboud University Medical Center 13
Radboud University Medical Centre – Key Competitors 14
Radboud University Medical Centre – Key Employees 15
Radboud University Medical Centre – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Radboud University Medical Centre, Pharmaceuticals & Healthcare, Key Facts 2
Radboud University Medical Centre, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Radboud University Medical Centre, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Radboud University Medical Centre, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Radboud University Medical Centre, Deals By Therapy Area, 2012 to YTD 2018 8
Radboud University Medical Centre, Medical Devices Deals, 2012 to YTD 2018 9
Radboud University Medical Centre, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Khondrion Enters into Collaboration Agreement with Nijmegen Center for Mitochondrial Disorders 11
Okklo Life Sciences Enters Into Agreement with Radboud University Nijmegen 12
ProQR Therapeutics Enters into Licensing Agreement with Radboud University Medical Center 13
Radboud University Medical Centre, Key Competitors 14
Radboud University Medical Centre, Key Employees 15
Radboud University Medical Centre, Subsidiaries 16

List of Figures
Radboud University Medical Centre, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Radboud University Medical Centre, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Radboud University Medical Centre, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Radboud University Medical Centre, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Radboud University Medical Centre, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Radboud University Medical Centre, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Radboud University Medical Centre, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Radboud University Medical Centre, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Radboud University Medical Centre, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Radboud University Medical Centre:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Petroleum & Chemical Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    China Petroleum & Chemical Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary China Petroleum & Chemical Corp (Sinopec Corp), a subsidiary of China Petrochemical Corporation, is a vertically integrated energy and chemical company. It is involved in the oil and …
  • Odfjell Drilling Ltd (ODL):企業の財務・戦略的SWOT分析
    Odfjell Drilling Ltd (ODL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Walsin Lihwa Corporation:企業の戦略・SWOT・財務情報
    Walsin Lihwa Corporation - Strategy, SWOT and Corporate Finance Report Summary Walsin Lihwa Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Accelya Solutions India Ltd (ACCELYA):企業の財務・戦略的SWOT分析
    Accelya Solutions India Ltd (ACCELYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Toyo Tire Corp (5105):企業の財務・戦略的SWOT分析
    Toyo Tire Corp (5105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Silverlake Axis Ltd:企業の戦略・SWOT・財務分析
    Silverlake Axis Ltd - Strategy, SWOT and Corporate Finance Report Summary Silverlake Axis Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Qinetiq Group Plc:企業の戦略・SWOT・財務分析
    Qinetiq Group Plc - Strategy, SWOT and Corporate Finance Report Summary Qinetiq Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Helix BioMedix Inc-製薬・医療分野:企業M&A・提携分析
    Summary Helix BioMedix Inc (Helix) is a dermatology and consumer skin care products company. It develops an extensive proprietary library of structurally diverse bioactive peptides for the applications in consumer skin care products and prescription products. Its peptides are used in cosmeceuticals, …
  • PT Soho Global Health Tbk (SOHO):企業の財務・戦略的SWOT分析
    PT Soho Global Health Tbk (SOHO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • CJ O Shopping Co.,Ltd (035760):企業の財務・戦略的SWOT分析
    CJ O Shopping Co.,Ltd (035760) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Taita Chemical Co, Ltd (1309):企業の財務・戦略的SWOT分析
    Taita Chemical Co, Ltd (1309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • First Gen Corporation (FGEN):電力:M&Aディール及び事業提携情報
    Summary First Gen Corporation (First Gen) a subsidiary of First Philippine Holding Corporation is a producer and distributor of electric power. It undertakes activities such as power generation, power distribution, infrastructure, manufacturing, and property development. The company together with it …
  • Alfred E. Tiefenbacher (GmbH & Co KG)-製薬・医療分野:企業M&A・提携分析
    Summary Alfred E. Tiefenbacher (GmbH & Co KG) (AET) is a healthcare products provider that develops active pharmaceuticals ingredients. The company’s products comprise cytotoxic drugs, hormones, OTC drugs, controlled drugs, herbal drugs, high potent drugs, new combination products, inhaler technolog …
  • Lipocine Inc (LPCN):企業の財務・戦略的SWOT分析
    Summary Lipocine Inc (Lipocine) operates as a pharmaceutical company that develops and commercializes treatment for men's and women's health. The company’s pipeline products for men’s health include LPCN 1111 and LPCN 1021; and for women’s health include LPCN 1107. Its LPCN 1111 is an oral testoster …
  • Duke Energy Carolinas LLC:企業の戦略的SWOT分析
    Duke Energy Carolinas LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Borealis AG:企業の戦略的SWOT分析
    Borealis AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Fresenius Kabi AG:企業の戦略的SWOT分析
    Fresenius Kabi AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Just Group plc:戦略・SWOT・企業財務分析
    Just Group plc - Strategy, SWOT and Corporate Finance Report Summary Just Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Mediacom Communications Corporation:企業の戦略的SWOT分析
    Mediacom Communications Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • juwi AG:企業の戦略的SWOT分析
    juwi AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆